183 related articles for article (PubMed ID: 38341398)
1. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
[TBL] [Abstract][Full Text] [Related]
2. Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma.
Xia X; He C; Wu A; Zhou J; Wu J
Dis Markers; 2018; 2018():8956072. PubMed ID: 29743960
[TBL] [Abstract][Full Text] [Related]
3. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
4. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
[TBL] [Abstract][Full Text] [Related]
5. Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients.
Xu J; Lv W; Hu Y; Wang L; Wang Y; Cao J; Hu J
J Cancer; 2017; 8(13):2523-2531. PubMed ID: 28900490
[No Abstract] [Full Text] [Related]
6. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
Front Oncol; 2022; 12():974614. PubMed ID: 36185284
[TBL] [Abstract][Full Text] [Related]
7. Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma.
Jiang W; Xu Z; Huang L; Qin F; Yuan L; Sun Y; Qin J; Deng K; Zheng T; Long X; Li S
BMC Med Genomics; 2023 Dec; 16(1):330. PubMed ID: 38110999
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
9. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
11. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
Xiong Y; Gu F; Cui J; Liu Y; Sun M; Gu X; Zhong L; Zhang K; Liu L
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15039-15053. PubMed ID: 37612389
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
[TBL] [Abstract][Full Text] [Related]
15. A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma.
Huang X; Feng Y; Li Y; Ding H; Huang X; Chen C; Yu Z; Zhang J; Xu X; Ma D; Yu S; Chen C
Int Immunopharmacol; 2024 Jan; 127():111286. PubMed ID: 38064818
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
17. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.
He J; Ni JP; Li GB; Yao J; Ni B
Clin Respir J; 2023 Mar; 17(3):197-210. PubMed ID: 36718941
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
20. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]